Pain

Latest News

Most Cannabis Customers Report Utilizing for Pain, Sleep Relief

De facto medical use of cannabis for symptom relief is common among adult-use dispensary customers in Colorado.

Novel vs Traditional Spinal Cord Stimulation Therapies for Chronic Low Back Pain

The use of novel waveforms, frequencies, and stimulation modes in spinal cord stimulation (SCS) therapies may be more effective at relieving chronic low back pain and/or leg pain compared with traditional tonic low-frequency SCS.

Stimulating Dorsal Root Ganglions Plus Dorsal Columns for Complex Pain Patterns

For certain patients with complex pain patterns, stimulating both dorsal root ganglion and dorsal columns may relieve pain effectively.

Direct-to-Doctor Payments May Increase Opioid Prescribing

Physicians who receive direct pharmaceutical payments for opioid prescribing prescribe more opioids, especially hydrocodone and oxycodone.

Mindfulness-Based Stress Reduction Also Benefits Chronic Pain

For patients with chronic pain (CP), both mindfulness-based stress reduction (MBSR) and cognitive behavioral therapy (CBT) improve physical functioning, pain intensity, and depression.

CDC: Opioid Prescribing Higher in Rural Versus Urban Areas

The percentage of individuals prescribed an opioid is higher in rural than urban areas.

FDA Approves Two New Strengths of Apadaz for Pain Management

Apadaz was initially approved in February 2018 as 6.12mg/325mg immediate-release tablets for the short-term (no more than 14 days) management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.

Ultrarestrictive Opioid Rx Protocol Cuts Postoperative Opioid Use

An ultrarestrictive opioid prescription protocol can reduce the number of opioids prescribed to patients after gynecologic and abdominal surgery without negative health consequences.

Pain Management Telementoring May Cut Opioid Prescribing

Military patients whose primary care clinicians participated in a telementoring program have larger declines in opioid-related prescriptions than patients whose clinicians did not participate.

FDA Panel Votes in Favor of Abuse-Deterrent Oxycodone Reformulation

The vote was taken in a joint meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management Advisory Committee.